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Abstract
Background: Radiotherapy is the keystone in brain tumor treatment, including posterior fossa tumors, and can achieve better 
patient health-related quality of life. Radiation exposure can be associated with the risk of skin radiation injuries. Accurate tumor 
and critical structure delineations and precise dose planning may improve the outcomes and decrease radiation complications. 
The objective of this study was to compare the influence of the headrest and treatment couch during dose planning, on the dose 
distributions and skin injury post irradiation.
Material and Methods: Treatment planning calculations were performed for 14 brain tumor patients using the volumetric 
modulated arc therapy (VMAT) to study the dose distribution and dose-volume histograms (DVH). We compared the following 
three cases of general patient contours: patient body contour alone, body contour including the headrest, and body contour with 
headrest, couch and immobilization mask. The same configuration beams were used in all these cases; general patient contours 
alone were altered.
Results: For dose estimations, the skin was delineated as a 2 mm layer beneath the patient’s body contour. The comparisons 
showed that the average dose on the skin, among all the patients included in this study, in the case of body contour alone is 3.3 
Gy, whereas in the case of body contour with headrest, it is 6.3 Gy and in the case of body contour with headrest, couch and 
immobilization mask it is 9.4 Gy. 
Conclusion: For brain tumors, located in the posterior fossa and near the patient’s skin, the skin needed to be included as a 
critical structure. The skin dose should be considered when evaluating treatment plans, taking into account the bolus effect of the 
headrest and couch.
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Introduction
Radiotherapy has been successfully applied in the 
field of oncology. The benefits of irradiation could be further 
improved by encouraging a better understanding of the normal 
skin reaction post radiation doses. In spite of the currently 
available advanced radiotherapy facilities, high radiation doses 
continue to induce dose-dependent skin reactions in the area 
treated [1, 2]. The severity of the irradiation effects  on the skin 
ranges from mild erythema (red rash) and dry desquamation 
(itchy, peeling skin) to more severe moist desquamation (open 
wound) and ulceration [3].
Skin reaction and injuries are dose dependent. The 
National Cancer Institute (NCI) has established a skin reaction 
grading system [4], according to which, the severity can 
range from grades 1 to 4, with 1 being the least severe and 4 
including the severest complications [5].
According to the NCI classification, skin reactions for 
doses up to 10 Gy are usually classified as grade 1. For doses 
lower than 2 Gy, the conventional rating is no skin reaction. 
Certain less serious effects like transient erythema and 
alopecia may occur in doses between 2 and 10 Gy.
Skin reactions that may be observed post doses between 
10 and 15 Gy belong to grades 1 and 2 of the NCI classification. 
Besides erythema and epilation, dry desquamation, 
telangiectasia and skin weakness are also possible.
The severest skin reaction (NCI grades 3 and 4) may 
occur at doses above 15 Gy. At these doses, edema, acute 
ulceration, dermal necrosis, dermal atrophy and/or indurations 
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and late skin breakdown are possible. In such cases surgical 
intervention may be required [5].
Posterior fossa brain tumors, similar to high grade 
gliomas, medulloblastomas, ependymomas, are usually 
subject to radiation therapy in the course of their treatment 
[6]. The whole brain can be exposed to radiation or it could be 
focused onto only a specific region of the brain. 
Based on the tumor location, size, grade and type of brain 
cancers, the standard radiation dose of 48-60 Gy is delivered 
in 1.8 to 3.0 Gy per fraction [7-10]. Treatment delineation is 
based on  MRI after fusion with CT images. New techniques 
for dose planning such as intensity modulated radiotherapy 
(IMRT) and VMAT have been provided for better dose 
conformity and allow limiting the sensitive tissues adjacent 
to the target. For some patients, the tumor is located close 
to the patient’s skin, especially for those patients who have 
undergone a prior surgery. In these cases, planning treatment 
volume (PTV) includes the patient’s skin. 
Usually, the dose calculation is restricted by patient 
body contour, although the radiotherapy beams from different 
angles can spread onto the treatment couch and headrest. 
Therefore, the actual dose is not restricted by patient body 
contour, as the couch and headrest definitely alter the dose 
distributions. 
The objective of this study was to compare the influence 
of the headrest and treatment couch during dose planning, on 
the dose distributions and skin injury post irradiation.
Material and Methods
The study was performed on 14 patients with brain 
tumors such as high grade gliomas (10 pts), medulloblastomas 
(2 pts), ependymomas (2 pts), which had been treated at the 
Center of Radiosurgery and Radiotherapy of the Meshalkin 
Research Institute of Circulation Pathology (Novosibirsk, 
Russia). In all the cases, irradiation had been performed using 
a stereotactic LINAC (Elekta Axesse, Elekta Instruments 
AB, Stockholm, Sweden) with thermoplastic masks to 
immobilize the patients. For patient comfort and additional 
set-up reproducibility, different headrests were used, to suit 
the patient’s anatomical features. 
A pretreatment CT scan was done using the CT scanner 
(Aquilion LB; Toshiba Medical Systems, Tokyo, Japan) and 
fusion of the images and delineation of the target and adjacent 
structures were performed using FocalPro workstation 
(Elekta Insruments AB). The dose was planned with the 
ERGO++ stereotactic treatment planning system (TPS) 
(Elekta Instruments AB). All treatment plans were calculated 
for 6 MeV energy on the Elekta Axesse LINAC and included 
VMAT technique. The doses were calculated with a 2-mm grid 
resolution. Eleven treatment plans (80%) had one noncoplanar 
arc added for optimal dose distribution. 
For each patient, three different contours were created. 
The first was the normal body contour, which was delineated 
with automated segmentation techniques in FocalPro. The 
headrest was included in the usual body contour in the case 
of the second case studied. For the third case, we manually 
delineated the headrest, couch and immobilization mask in 
addition to body contour. 
The skin was delineated as a 2-mm layer beneath the 
patient’s body contour. The head skin (scalp and facial skin) 
alone was included in the estimations.
Dose distributions were then calculated for the first case 
without the use of immobilization devices (case 1). Other 
cases were recalculated with the same beam configurations as 
for case 1. The DVH were analyzed.
Results
A total of 14 patients were included in the current study. 
From the database of brain tumor patients, only those with 
tumors located in the posterior fossa were selected.
Table 1 presents the patient’s clinical characteristics 
and treatment details such as PTV and total dose. Fig. 1 
demonstrates the doses to the skin for the cases studied. 
The comparisons showed that the average dose on the 
skin, among all the patients included in this study, in the case 
Table 1.
The patient’s clinical characteristics and treatment details
Patient 
No.
Sex Age Type of tumor PTV
 (cm3)
Total dose, 
Gy
1 F 41 AA 122 48
2 M 51 GBM 310  60
3 M 28 GMB 71 54
4 M 5 medulloblastoma 21 53.2
5 F 51 AA 357 60
6 M 42 ependymoma 245 54
7 F 5 medulloblastoma 14 53.1
8 F 33 AA 120 48
9 M 28 GBM 71 54
10 M 7 GBM 51 50,4
11 F 48 GMB 327 60
12 M 5 ependymoma 108 55,8
13 F 45 AA 417 60
14 F 48 GBM 379 60
Abbreviations: F- Female; M- Male; AA - anaplastic astrocytoma; 
GBM - glioblastoma. 
Figure 1. 
Doses to the skin for studied case: 1) blue points – only patient’s body 
contour, 2) green points – body contour including headrest, 3) red 
points – body contour with headrest, couch and immobilization mask.285 O. A. Pashkovskaya et al / International Journal of BioMedicine 3(4) (2013) 283-286
of body contour alone is 3.3 Gy, whereas in the case of body 
contour with headrest, it is 6.3 Gy and in the case of body 
contour with headrest, couch and immobilization mask it is 
9.4 Gy (Figure 2 and 3). Figure 3 shows the DVH for the 
methods studied regarding body contour delineations.
Discussion
Skin dose during radiotherapy is one of the important 
factors associated with complications in radiation therapy and 
influences patient’s health-related quality of life. Of note, some 
studies have showed an association between radiation therapy 
and basal-cell carcinoma induction [11-13]. Until recently, 
only a few studies have been conducted on the accuracy of 
skin dose calculation [14, 15]. According to this paper the 
skin dose load calculation is generally provided within ±25% 
accuracy. The use of thermoplastic immobilization masks 
increases the skin dose [16, 17]. The optimization strategy 
during planning and multiple tangential beams can increase 
the skin dose [15]. Court et al. [15] reported an agreement 
between the skin doses calculated by Eclipse TPS and those 
measured by micro-MOSFET (metal oxide semiconductor 
field effect transistors), and the hemispheric phantom dose 
was within ±20% for 95% of all the points measured. 
In the current paper, the influence of the headrest and 
treatment couch during dose planning on dose distributions 
was investigated by including them in the calculation volume. 
Fig. 1 shows that using the actual body contour for dose 
calculation is an underestimation of the dose on the patient’s 
body surface. One of the patients was administered a 5.6 Gy 
dose to the skin, calculated without taking into account the 
immobilization devices. Moist desquamation was observed 
as an early side effect of the irradiation. After recalculation 
of the treatment plan including the headrest and couch, the 
ideal planning dose to the skin was found to be 15.6 Gy. Figs. 
2 and 3 also demonstrate examples of increasing the dose to 
the skin for patients with ependymoma, at PTV=245 cm3 after 
recalculation. Dose isolines spread to the headrest and couch 
through the skin, contrary to the case with actual body contour, 
where they are concentrated just beneath the skin surface. The 
DVH also indicates the increasing dosage to the skin.
Conclusion
For patients with tumors located in the posterior fossa 
and/or near the patient’s skin, more accurate skin dose 
calculation is required. Also, the bolus effect of the headrest 
and couch should be considered when evaluating the treatment 
plans. 
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